Evidence map›Paper›PMID 42075860›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies.

Eleni A Karavia, Andreas Pittaras, Ourania Andreopoulou, Aikaterini Hatziri, Amalia Makrydimitri, Dimitrios Anagnostopoulos, Patroklos Vareltzis, Kyriakos E Kypreos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eleni A KaraviaPharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece.ORCID 0009-0004-6463-8481
Andreas PittarasPharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece.ORCID 0000-0002-8688-4067
Ourania AndreopoulouPharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece.ORCID 0000-0003-2011-8930
Aikaterini HatziriPharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece.
Amalia MakrydimitriAdelco SA, 18346 Moschato, Greece.
Dimitrios AnagnostopoulosAdelco SA, 18346 Moschato, Greece.
Patroklos VareltzisLaboratory of Industrial Food Technologies and Agricultural Industries Technologies, Chemical Engineering Department, Faculty of Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-4796-183X
Kyriakos E KypreosPharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece.ORCID 0000-0001-6784-2710

Funding

Hellenic Ministry of Education, Religious Affairs and Sports 3DPharma_ΥP3ΤΑ-0560399 under the program Partnerships for Research Excellence - PRE
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

development and evaluationevidence-based managementGRADE evaluationgrading of recommendations assessmentmedicinesmetabolic dysfunction-associated liver diseasenon-alcoholic fatty liver disease

Identifiers

PMID42075860
PMCPMC13119189

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.